TITLE

2008 - Review: Statins are effective for prevention of cardiovascular events in patients without coronary heart disease

AUTHOR(S)
McAlister, Finlay A.
PUB. DATE
April 2009
SOURCE
ACP Journal Club;4/21/2009, Vol. 150 Issue 4, p3
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses whether statins are effective for primary prevention of cardiovascular (CV) events. Medical studies comparing statins with placebo, standard therapy, or no treatment for primary prevention were taken into account. Meta-analysis showed that statins reduces all-cause mortality, CV mortality, all MI, fatal myocardial infarction (MI), stroke, and major risk factors associated with the disease in comparison with placebo
ACCESSION #
39257760

 

Related Articles

  • Serum lipoprotein levels in takotsubo cardiomyopathy vs. myocardial infarction. Gaddam, Sainath; Nimmagadda, Krishna C.; Nagrani, Tarun; Naqi, Muniba; Wetz, Robert V.; Weiserbs, Kera F.; McCord, Donald; Ghavami, Foad; Gala, Bhavesh; Lafferty, James C. // International Archives of Medicine;2011, Vol. 4 Issue 1, p14 

    Background: In the setting of myocardial infarction (MI) or acute coronary syndrome (ACS), current guidelines recommend early and aggressive lipid lowering therapy with statins, irrespective of the baseline lipoprotein levels. Takotsubo cardiomyopathy (TCM) patients have a clinical presentation...

  • Review: Statins reduce mortality and cardiovascular events in adults at risk for cardiovascular disease. Davidson, Richard A.; Rosenberg, Eric; Brugts, J. J. // ACP Journal Club;10/20/2009, Vol. 151 Issue 4, p11 

    The article discusses a study conducted to examine if statins reduce mortality in adults without established cardiovascular disease (CVD) but with CVD risk factors. The results indicated positivity in statins reducing mortality and cardiovascular events. Later it was also found that the...

  • A Rationale for Combined Therapy with a Calcium Channel Blocker and a Statin: Evaluation of Basic and Clinical Evidence. Mason, R. Preston // Current Drug Targets - Cardiovascular & Haematological Disorders;Dec2005, Vol. 5 Issue 6, p489 

    Calcium channel blockers and HMG-CoA reductase inhibitors are widely used for the management of hypertension and dyslipidemia, respectively. The use of these agents in the prevention and treatment of cardiovascular disease remains largely based on their actions in lowering blood pressure and...

  • The Miracle of Niacin. Agatston, Arthur // Prevention;May2009, Vol. 61 Issue 5, p34 

    The article discusses a University of Washington study that shows the benefits of high doses of niacin when taken with statin drugs in lowering the risk factors for heart attack. When taken with statin drugs, niacin raises HDL cholesterol and lowers triglycerides, enlarges the smallest particles...

  • Results from the ACCORD Lipid Study.  // MD Conference Express;May2010, p11 

    The article discusses the results of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Lipid Study, which was presented in the American College of Cardiology (ACC) 59th Annual Scientific Session. It says that the ACCORD Lipid Study does not encourage the use of combined statin and...

  • Efficacy of Standard and Intensive Statin Treatment for the Secondary Prevention of Cardiovascular and Cerebrovascular Events in Diabetes Patients: A Meta-Analysis. de Vries, Folgerdiena M.; Kolthof, Johan; Postma, Maarten J.; Denig, Petra; Hak, Eelko // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    Aims: To estimate the efficacy of standard and intensive statin treatment in the secondary prevention of major cardiovascular and cerebrovascular events in diabetes patients. Methods: A systematic search was conducted in Medline over the years 1990 to September 2013. Randomized, double-blind,...

  • Inflammatory findings. Comarow, Avery // U.S. News & World Report;1/17/2005, Vol. 138 Issue 2, p74 

    Discusses the idea that doctors should be aggressive in prescribing stains for heart attack patients. The role of C-reactive protein as a signal of inflammation associated with coronary artery disease; Research by Christopher Cannon, cardiologist at Brigham and Women's Hospital in Boston;...

  • Serum cholesterol as a risk factor for coronary heart disease revisited. Rossouw, J. E. // South African Journal of Clinical Nutrition;2015, Vol. 28 Issue 1, p34 

    The biology of lipoproteins and lipoprotein particles as mediators of atherosclerosis has been documented extensively. Numerous prospective epidemiological studies have shown a robust relationship between low-density lipoprotein (LDL) cholesterol, or particles bearing apolipoprotein B, and...

  • Dr Foster's case notes.  // BMJ: British Medical Journal (International Edition);9/18/2004, Vol. 329 Issue 7467, p645 

    Examines the relationship between the prescribing of lipid regulating drugs or statins to the number of admissions for myocardial infarction in England. Conduct of the study; Finding that the large increase in the cost and volume of the prescribing of lipid regulating drugs has been associated...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics